Jentadueto 2.5 MG / 1000 MG Oral Tablet
- RxCUI
- 1243026
- RxNorm name
- Jentadueto 2.5 MG / 1000 MG Oral Tablet
- Display name
- Jentadueto 2.5 MG / 1000 MG Oral Tablet
- Full name
- Jentadueto 2.5 MG / 1000 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:28
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Jentadueto | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | f6dd9b86-0d18-95d4-2bc7-05591bfdd597 | 2026-08-19 | Boxed warning, Warnings, Adverse reactions | 1243026 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f6dd9b86-0d18-95d4-2bc7-05591bfdd597 | Jentadueto 2.5 MG / 1000 MG Oral Tablet [PSN] · linagliptin 2.5 MG / metformin hydrochloride 1000 MG Oral Tablet [Jentadueto] [SBD] · Jentadueto 2.5/1000 Oral Tablet [SY] | 3 | 45 | These highlights do not include all the information needed to use JENTADUETO safely and effectively. See full prescribing information for JENTADUETO. JENTADUETO ® (linagliptin and metformin hydrochloride tablets), for oral use Initial U.S. Approval: 2012 | 20240627 |
| 9822b5fa-6024-445a-a36d-a26106c69845 | Jentadueto 2.5 MG / 1000 MG Oral Tablet [PSN] · linagliptin 2.5 MG / metformin hydrochloride 1000 MG Oral Tablet [Jentadueto] [SBD] · Jentadueto 2.5/1000 Oral Tablet [SY] | 3 | 2 | These highlights do not include all the information needed to use JENTADUETO safely and effectively. See full prescribing information for JENTADUETO. Jentadueto ® (linagliptin and metformin hydrochloride) tablets Initial U.S. Approval: 2012 | 20150506 |